Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
20.2M
-
Shares change
-
+171K
-
Total reported value, excl. options
-
$1.34B
-
Value change
-
+$12M
-
Put/Call ratio
-
0.87
-
Number of buys
-
120
-
Number of sells
-
-108
-
Price
-
$66.36
Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2024
267 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q1 2024.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.2M shares
of 22.5M outstanding shares and own 90.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.35M shares), Conestoga Capital Advisors, LLC (1.93M shares), VANGUARD GROUP INC (1.55M shares), Copeland Capital Management, LLC (1.29M shares), GENEVA CAPITAL MANAGEMENT LLC (900K shares), Ranger Investment Management, L.P. (824K shares), STATE STREET CORP (793K shares), CONGRESS ASSET MANAGEMENT CO /MA (666K shares), DIMENSIONAL FUND ADVISORS LP (662K shares), and GEODE CAPITAL MANAGEMENT, LLC (478K shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.